New fast-acting cannabis infusion powder ingredient from Vertosa

California-based Vertosa, known for infusing nearly 100 cannabis products on the market, is releasing an advanced new scientific solution to support the next generation of infused products: Powder-based Cannabis Emulsion. Chief Science Officer/Founder Dr. Harold Han, Director of Technical Services & Sales Lauren Tamburro and their team developed the proprietary formula, one of the few powders currently available on the market.

Vertosa broke onto the scene in 2018 by developing liquid emulsions to mix the insoluble – cannabis oil and water – in order to infuse beverages and topicals with THC, CBD and other cannabinoids and provide better taste, faster onset, and product stability. With the team’s newly developed fast-acting powder emulsion, product makers can develop cannabis products across even more categories.

“Powder emulsions provide valuable versatility and flexibility,” said Vertosa Chief Innovation Officer Austin Stevenson. “With this solution, product makers can address a much wider set of product categories, from beverage enhancers to pressed tablets, fillable capsules, wholesale nutritional supplements and more. Beyond strictly supplements, baked goods and bars also respond well to powder emulsions.”

The Science Powering the Powder
Vertosa is currently offering their brand partners two different types of powder: CBD Isolate and CBD Broad Spectrum (both THC-free). The powders are packed in a nitrogen atmosphere to ensure a long shelf life. The active ingredients are stable and disperse easily in both hot and cold water. The small droplet size of the CBD upon rehydration enables fast-acting effects.

Vertosa also completed an extensive study of the powders in both loose and bagged tea applications at Anresco Laboratories. The teas were steeped in hot water to simulate the customers’ experience; the testing verifies the CBD droplets easily traverse the tea bag barrier, so the consumer will get the full amount of CBD promised on each product’s label.

“This crucial study confirms precise and accurate dosing, ensuring consumers will get what they pay for,” said Tamburro.